Although these results are not enough to directly influence clinical practice at present, they would be helpful for future research on the establishment of diagnostic or predictive models of PFS and OS for advanced lung cancer patients treated with PD-1/PD-L1 inhibitors plus chemotherapy. The gene discussed is PDCD1; the disease is lung carcinoma.